TME Pharma to Fund Via New Bond and Claim a New Notice of Shareholding Announcement TME pharma NV, a known clinical-stage biotechnology company pioneering in the development of therapies for eye disease and cancer, has stepped into fundraising of €500,000 to stabilize its financial capacity...
Sonic Acquired Cairo to Expand Hematology Oncology Testing Announcement Sonic Healthcare USA Inc has acquired all assets of Cairo Diagnostics LLC, Cairo Diagnostics NJ LLC, and Rye Management and Logistics Corp (its related to Cairo). Cairo is a reputable provider of inclusive hematology and onc...
Cambrexs New Manufacturing Destination in Waltham, Massachusetts Announcement Cambrex, a popular global contract development and manufacturing organization (CDMO), declared that Snapdragon chemistry cambrex company has extended its active pharmaceutical ingredient (API) facility in Waltham, Mass...
Roche Canada Received Market Authorization for a Drug Cpmbined with GemOx Announcement Hoffmann-La Roche Limited (Roche Canada) received a market authorization officially by Health Canada for Columvi (glofitamab for injection), in combination with gemcitabine and oxaliplatin (GemOx), suitable fo...
Malaysia’s Robust Healthcare Highlights in Cambodia Announcement The Malaysia Healthcare Travel Council (MHTC) introduced Malaysia Healthcare Week 2025 in Phnom Penh, Cambodia. The week is an effort highlighted to foster healthcare professional relations between the two nations and positio...
Thermo Fisher’s New Manufacturing Center in North Carolina Announcement The Thermo Fisher Scientific Inc., the global leader in delivering science, has opened its creative manufacturing center of brilliant facility in Mebane, N.C. The new site of carbon neutral is a 375,000 square foot fac...
Moffitt and PathAI’s Partnership to Initiate Digitalization Announcement PathAI, a known leader in digital pathology solutions and artificial intelligence, entered a multi-year partnership with Moffitt Cancer Center, one of the popular cancer hospitals and a global leader in cancer researc...
Invivyd Priced its Public Offering of Common Stock and Pre-funded Warrants in Millions Announcement Invivyd Inc. has revealed the pricing of an underwritten public offering of 74,811,404 shares of its common stock at a price of the offering by $0.52 per share for specific investors instead of co...
LinusBio’s ClearStrand-ASD has Entered Japan Announcement LinusBio, a popular player in precision exposome medicine, proudly declared that Clearstrand-ASD, its biochemical autism screening test, is available in Japan for research purposes via a partnership with YAC bio. This successful ste...
CORL Technologies and RiskRecon by Mastercard Entered into a Partnership for a Strong Purpose Announcement CORL Technologies, the leading healthcare company managing third-party risk management (TPRM) solutions, has entered a partnership with Mastercard. The partnership will merge Masterca...
